WVE vs PHAR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

WVE

30.7
AI Score
VS
WVE Wins

PHAR

23.1
AI Score

Investment Advisor Scores

WVE

31score
Recommendation
AVOID NEW MONEY

PHAR

23score
Recommendation
STRONG SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric WVE PHAR Winner
Forward P/E 0 270.2703 Tie
PEG Ratio 0 0 Tie
Revenue Growth 73.0% 20.8% WVE
Earnings Growth 0.0% 74.9% PHAR
Tradestie Score 30.7/100 23.1/100 WVE
Profit Margin -296.9% 6.2% PHAR
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY STRONG SELL WVE

Relative Price Performance (Last 90 Days)

WVE 1M: -1.9% · 3M: -38.5% PHAR 1M: +30.8% · 3M: +6.9%

Current Technical Phase

WVE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -16.4%), weak momentum, RSI 38

RSI (14): 37.6 · Price: $3.13

PHAR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.0% over 20 days), RSI 60

RSI (14): 59.8 · Price: $12.60

Fundamentals Snapshot

Metric WVE PHAR
Market Cap — —
Forward P/E -2.7 70.0
Trailing P/E — 39.4
Revenue (TTM) — —
Revenue Growth 0.7% 0.2%
Gross Margin -1.9% 0.9%
Operating Margin -3.2% 0.1%
EPS -1.07 0.32
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, WVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.